Don’t miss the latest developments in business and finance.

Glenmark receives USFDA approval for Topiramate Capsules

Image
Last Updated : Jul 17 2024 | 12:17 PM IST

Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (U.S. FDA) for Topiramate Capsules USP, 15 mg and 25 mg. Glenmark's Topiramate Capsules USP, 15 mg and 25 mg has been determined by the FDA to be bioequivalent and therapeutically equivalent1 to Topamax2 Capsules, 15 mg and 25 mg of Janssen Pharmaceuticals, Inc., and will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA.

According to IQVIATM sales data for the 12-month period ending May 2024, the Topamax Capsules, 15 mg and 25 mg market achieved annual sales of approximately $21.9 million.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jul 17 2024 | 12:08 PM IST

Next Story